EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Pathway‐based polygenic risk of Alzheimer's disease highlights immune genes in cognitive decline

Emilija Romic, Ida Karlsson, Nina Karalija, Annelie Nordin Adolfsson, Rolf Adolfsson, Karolina Kauppi iD

Alzheimer's & Dementia: Translational Research & Clinical Interventions · 2026-01 · 12 (1)

DOI: 10.1002/trc2.70209 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia: Translational Research & Clinical Interventions, online erschienen am 08.02.2026. Verfasst von Emilija Romic und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical and Translational Biology Umeå University, Johan Bures väg 12, 901 87 Umeå Sweden. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Vetenskapsrådet, Hjärnfonden.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION Alzheimer's disease (AD) is a genetically heterogeneous disease, with various genetic variants potentially influencing disease mechanisms differently. Pathway‐based polygenic risk scores (p‐PRS) can be used to examine how groups of risk genes with similar biological functions impact disease‐related endophenotypes such as cognitive decline. potentially aiding in differentiating pre‐clinical dementia from normal age‐related cognitive decline. METHODS Data from 1,737 participants (53.5% female) from the Betula study were analyzed. AD‐weighted p‐PRS were calculated for five AD‐related pathways: immune response, tau, cholesterol, protein–lipid, and amyloid. The p‐PRS were tested for associations with all‐cause dementia risk ( n = 315 cases), with follow‐up analyses restricted to AD ( n = 168) or vascular dementia (VD) ( n = 110), in comparison to a genome‐wide (gw) PRS. Linear mixed effect models were used to examine the same genetic predictors in relation to cognitive decline in subsequently demented and non‐demented. RESULTS All‐cause dementia risk was significantly predicted by the gw‐ and immune PRS. Hazard ratios for gw‐, immune‐, tau‐, cholesterol‐, and amyloid p‐PRS were larger for prediction of AD risk and smaller for VD risk relative to all‐cause dementia, while the opposite was seen for the protein–lipid p‐PRS. Cognitive decline was stronger associated with the immune p‐PRS than the gw‐PRS, and this effect was driven by participants that remained non‐demented (linear age‐effects). Amyloid p‐PRS showed accelerated age‐effect at the oldest age in both non‐demented and subsequently demented. DISCUSSION Our results show that AD‐weighted p‐PRS have differential roles on dementia risk and cognitive decline. Specifically, results suggest a broad role of immune p‐PRS in both age‐related cognitive decline and dementia risk, while amyloid p‐PRS influences AD risk and pre‐clinical cognitive decline, and protein‐lipid p‐PRS does not influence AD risk nor cognitive decline but show a potential role in VD. Results are of value for development of precision medicine based on genetic risk profiling. Highlights All‐cause dementia and Alzheimer's disease (AD) risk is strongest predicted by apolipoprotein E ( APOE) ε4 and global polygenic risk scores (PRS). Cognitive decline is stronger predicted by immune pathway‐based PRS (p‐PRS) relative to global PRS. Effect of APOE ε4 on cognitive decline is driven by pre‐clinical dementia. Immune p‐PRS predicts cognitive decline unrelated to subsequent dementia. Protein–lipid p‐PRS may have a stronger role in vascular dementia than AD.

Schlagwörter

Stichwörter der Autor:innen

Alzheimer's diseasecognitive agingdementiagene pathwaypolygenic risk score

Autor:innen und Institutionen

  • Department of Medical and Translational Biology Umeå University, Johan Bures väg 12, 901 87 Umeå Sweden.
  • Department of Medical Epidemiology and Biostatistics Karolinska Institute, 171 77 Stockholm Sweden.
  • Department of Clinical Sciences Umeå University, Psychiatry, 901 85 Umeå Sweden.

ORCID-Profile: Karolina Kauppi

Förderung

  • Vetenskapsrådet
  • Hjärnfonden

Zitieren

APA

Romic, E., Karlsson, I., Karalija, N., Adolfsson, A. N., Adolfsson, R., & Kauppi, K. (2026). Pathway‐based polygenic risk of Alzheimer's disease highlights immune genes in cognitive decline. Alzheimer's & Dementia: Translational Research & Clinical Interventions, 12(1). https://doi.org/10.1002/trc2.70209

Vancouver

Romic E, Karlsson I, Karalija N, Adolfsson AN, Adolfsson R, Kauppi K. Pathway‐based polygenic risk of Alzheimer's disease highlights immune genes in cognitive decline. Alzheimer's & Dementia: Translational Research & Clinical Interventions. 2026;12(1). doi:10.1002/trc2.70209

BibTeX
@article{Romic2026,
  author = {Romic, Emilija and Karlsson, Ida and Karalija, Nina and Adolfsson, Annelie Nordin and Adolfsson, Rolf and Kauppi, Karolina},
  title = {Pathway‐based polygenic risk of Alzheimer's disease highlights immune genes in cognitive decline},
  journal = {Alzheimer's & Dementia: Translational Research & Clinical Interventions},
  year = {2026},
  volume = {12},
  number = {1},
  doi = {10.1002/trc2.70209}
}
Kostenlos starten →